Glutamine is recognized as a critical amino acid involved in immunity, intestinal health, and nitrogen transport between organs. Prior to the pivotal study by Griffiths and colleagues in 1997, no clinical trials had demonstrated a positive effect from glutamine supplementation on improving long-term survival in critically ill intensive care unit patients receiving parenteral nutrition. Subsequent investigations have confirmed these findings, but further data are needed to determine the optimal dose and timing of glutamine as well as the form of glutamine (ie, free vs dipeptide) that produces the most significant improvement in outcome parameters. (Nutr Clin Pract. 2011;26:44-47)
Griffiths RD , Jones C., Palmer TESix-month outcome of critically ill patients given glutamine supplemented parenteral nutrition. Nutrition . 1997;13:295-302.
2.
Calder PC, Yaqoob P.Glutamine and the immune system. Amino Acids. 1999;17:227-241.
3.
Manhart N., Vierlinger K., Spittler A., Bergmeister H., Sautner T., Roth E.Oral feeding with glutamine prevents lymphocyte and glutathione depletion of Peyer’s patches in endotoxemic mice. Ann Surg. 2001;234:92-97.
4.
Hong RW, Rounds JD, Helton WS, Robinson MK, Wilmore DWGlutamine preserves liver glutathione after lethal hepatic injury. Ann Surg. 1992;215:114-119.
5.
Cao Y., Feng Z., Hoos A., Klimberg VSGlutamine enhances gut glutathione production. JPEN J Parenter Enteral Nutr. 1998;22:224-227.
6.
Wischmeyer PEGlutamine and heat shock protein expression . Nutrition. 2002;18:225-228.
7.
Coëffier M., Déchelotte P.The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome . Nut Rev. 2005;63:65-69.
8.
Huang Y., Li N., Liboni K., Neu J.Glutamine decreases lipopolysaccharide-induced IL-8 production in Caco-2 cells through a non-NF-κB p50 mechanism. Cytokine. 2003;22:77-83.
9.
Marion R., Coëffier MM, Gargala G., Ducrotté P., Déchelotte P.Glutamine and CSX chemokines IL-8, Mig, IP-10 and I-TAC in human intestinal epithelial cells. Clin Nutr. 2004;23:579-585.
10.
Fürst P., Pogan K., Stehle P.Glutamine dipeptides in clinical nutrition . Nutrition. 1997;13:731-737.
Canadian Critical Care Nutrition Clinical Guidelines.Summary of topics and recommendations. Critical care nutrition. http://www.criticalcarenutrition.com/docs/cpg/srrev.pdf . Published May 28 2009. Accessed October 18, 2010 .
13.
Wang Y., Jiang ZM, Nolan MT, et al. The impact of glutamine dipeptide-supplemented parenteral nutrition on outcomes of surgical patients: a meta-analysis of randomized clinical trials . JPEN J Parenter Enteral Nutr. 2010;34:521-529.
14.
Jo S., Choi SH, Heo JS, et al. Missing effect of glutamine supplementation on the surgical outcome after pancreaticoduodenectomy for periampullary tumors: a prospective, randomized, double-blind, controlled clinical trial. World J Surg. 2006;30:1974-1982.
15.
Estivariz CF , Griffith DP, Luo M., et al. Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients. JPEN J Parenter Enteral Nutr. 2008;32:389-402.
16.
Novak F., Heyland, Avenell A, Drover JW, Su X.Glutamine supplementation in serious illness: a systematic review of the evidence . Crit Care Med. 2002;30:2022-2029.
